- Home
- NSIT vs AXSM Comparison
NSIT vs AXSM Comparison
Compare NSIT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- AXSM
- Stock Information
- Founded
- NSIT 1988
- AXSM 2012
- Country
- NSIT United States
- AXSM United States
- Employees
- NSIT N/A
- AXSM N/A
- Industry
- NSIT EDP Services
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- NSIT Technology
- AXSM Health Care
- Exchange
- NSIT Nasdaq
- AXSM Nasdaq
- Market Cap
- NSIT 4.3B
- AXSM 5.1B
- IPO Year
- NSIT 1995
- AXSM 2015
- Fundamental
- Price
- NSIT $131.57
- AXSM $100.69
- Analyst Decision
- NSIT Buy
- AXSM Strong Buy
- Analyst Count
- NSIT 4
- AXSM 16
- Target Price
- NSIT $185.00
- AXSM $170.50
- AVG Volume (30 Days)
- NSIT 273.2K
- AXSM 659.8K
- Earning Date
- NSIT 07-31-2025
- AXSM 08-04-2025
- Dividend Yield
- NSIT N/A
- AXSM N/A
- EPS Growth
- NSIT N/A
- AXSM N/A
- EPS
- NSIT 5.12
- AXSM N/A
- Revenue
- NSIT $8,425,769,000.00
- AXSM $432,157,000.00
- Revenue This Year
- NSIT $3.19
- AXSM $62.84
- Revenue Next Year
- NSIT $4.72
- AXSM $60.02
- P/E Ratio
- NSIT $25.69
- AXSM N/A
- Revenue Growth
- NSIT N/A
- AXSM 72.16
- 52 Week Low
- NSIT $126.10
- AXSM $72.02
- 52 Week High
- NSIT $228.07
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- NSIT 45.78
- AXSM 37.30
- Support Level
- NSIT $130.58
- AXSM $99.39
- Resistance Level
- NSIT $139.72
- AXSM $112.98
- Average True Range (ATR)
- NSIT 3.61
- AXSM 3.33
- MACD
- NSIT 0.16
- AXSM -0.76
- Stochastic Oscillator
- NSIT 36.13
- AXSM 9.35
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.